YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2024Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer ONCOLOGIST
2024Analysis of Response and Progression Patterns of Tyrosine Kinase Inhibitors in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Post Hoc Analysis of Two KCSG Phase II Trials CANCER RESEARCH AND TREATMENT
2024PPFL: A personalized progressive federated learning method for leveraging different healthcare institution-specific features ISCIENCE
2024Association between Age-Adjusted Endothelial Activation and Stress Index and Intensive Care Unit Mortality in Patients with Severe COVID-19 TUBERCULOSIS AND RESPIRATORY DISEASES
2024Age- and ethnic-driven molecular and clinical disparity of East Asian breast cancers BMC MEDICINE
2024Similarity analyses of causative viruses for chronic obstructive pulmonary disease and asthma exacerbations : Author BMC PULMONARY MEDICINE
2024Reply to A. Okeya et alJOURNAL OF CLINICAL ONCOLOGY
2024Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSAANNALS OF ONCOLOGY
20242024 KSoLA Consensus on Secondary Dyslipidemia Journal of Lipid and Atherosclerosis
2024Pressure-responsive pH-triggered layer-by-layer coating of paclitaxel-eluting balloon catheters for instant high-dose drug delivery for percutaneous coronary artery interventionNANO RESEARCH
2024Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutationLUNG CANCER
2024SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 DiabetesNEUROLOGY
2024Efficacy and Safety of Pioglitazone Add-on in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin and Dapagliflozin: A Multicenter, Randomized, Double-blind, and Placebo-controlled StudyCLINICAL THERAPEUTICS
2024The position of loco-regional therapy in the management of hepatocellular carcinoma with extrahepatic metastases Journal of Liver Cancer(대한간암학회지)
2024Safety and anti-tumor activity of BAY 2927088 in patients with <i>HER2</i>-mutant NSCLC: Results from an expansion cohort of the SOHO-01 phase I/II study.JOURNAL OF CLINICAL ONCOLOGY
2024Subcutaneous amivantamab and lazertinib as first-line treatment in patients with <i>EGFR</i>-mutated, advanced non-small cell lung cancer (NSCLC): Results from the phase 2 PALOMA-2 study.JOURNAL OF CLINICAL ONCOLOGY
2024ADRIATIC: Durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)JOURNAL OF CLINICAL ONCOLOGY
2024Palbociclib plus exemestane with GnRH agonist vs capecitabine in premenopausal patients with HR+/HER2-metastatic breast cancer: Updated survival results of the randomized phase 2 study Young-PEARL.JOURNAL OF CLINICAL ONCOLOGY
2024A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trialJOURNAL OF CLINICAL ONCOLOGY
2024Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancerCANCER LETTERS
1 50 5152535455565758596061 771

Recent Submissions

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links